Cargando…

Oligosaccharides as Potential Therapeutics against Atherosclerosis

Atherosclerosis is the major cause of cardiovascular-disease-related death worldwide, resulting from the subendothelial accumulation of lipoprotein-derived cholesterol, ultimately leading to chronic inflammation and the formation of clinically significant atherosclerotic plaques. Oligosaccharides ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dabravolski, Siarhei A., Sukhorukov, Vasily N., Melnichenko, Alexandra A., Khotina, Victoria A., Orekhov, Alexander N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386248/ https://www.ncbi.nlm.nih.gov/pubmed/37513323 http://dx.doi.org/10.3390/molecules28145452

Ejemplares similares

Potential Application of the Plant-Derived Essential Oils for Atherosclerosis Treatment: Molecular Mechanisms and Therapeutic Potential
por: Dabravolski, Siarhei A., et al.
Publicado: (2023)

The Role of Selenium in Atherosclerosis Development, Progression, Prevention and Treatment
por: Dabravolski, Siarhei A., et al.
Publicado: (2023)

The Role of the VEGF Family in Atherosclerosis Development and Its Potential as Treatment Targets
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

Signaling Pathways and Key Genes Involved in Regulation of foam Cell Formation in Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2020)

The Role of Mitochondrial DNA Mutations in Cardiovascular Diseases
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

Molecular Mechanisms Underlying Pathological and Therapeutic Roles of Pericytes in Atherosclerosis
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

Lipid Metabolism in Macrophages: Focus on Atherosclerosis
por: Sukhorukov, Vasily N., et al.
Publicado: (2020)

Heat Shock Protein 90 as Therapeutic Target for CVDs and Heart Ageing
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

Is There a Relationship between Adverse Pregnancy Outcomes and Future Development of Atherosclerosis?
por: Poznyak, Anastasia V., et al.
Publicado: (2023)

Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease
por: Blagov, Alexander V., et al.
Publicado: (2023)

Modulating mTOR Signaling as a Promising Therapeutic Strategy for Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Creation of Mitochondrial Disease Models Using Mitochondrial DNA Editing
por: Khotina, Victoria A., et al.
Publicado: (2023)

Mitochondria-Mediated Cardiovascular Benefits of Sodium-Glucose Co-Transporter 2 Inhibitors
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

The Role of Mitochondrial Abnormalities in Diabetic Cardiomyopathy
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

Interplay between Zn(2+) Homeostasis and Mitochondrial Functions in Cardiovascular Diseases and Heart Ageing
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

Significance of Mitochondrial Dysfunction in the Progression of Multiple Sclerosis
por: Blagov, Alexander V., et al.
Publicado: (2022)

Atheroprotective Aspects of Heat Shock Proteins
por: Poznyak, Anastasia V., et al.
Publicado: (2023)

Endoplasmic Reticulum Stress in Macrophages: The Vicious Circle of Lipid Accumulation and Pro-Inflammatory Response
por: Sukhorukov, Vasily N., et al.
Publicado: (2020)

Mechanisms of the Wnt Pathways as a Potential Target Pathway in Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2023)

From Diabetes to Atherosclerosis: Potential of Metformin for Management of Cardiovascular Disease
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

The Role of Mitochondria-Derived Peptides in Cardiovascular Diseases and Their Potential as Therapeutic Targets
por: Dabravolski, Siarhei A., et al.
Publicado: (2021)

Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible?
por: Churov, Alexey V., et al.
Publicado: (2023)

NADPH Oxidases and Their Role in Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2020)

The Role of Pericytes in Regulation of Innate and Adaptive Immunity
por: Dabravolski, Siarhei A., et al.
Publicado: (2023)

The role of monocytosis and neutrophilia in atherosclerosis
por: Chistiakov, Dimitry A., et al.
Publicado: (2018)

Glycation of LDL: AGEs, impact on lipoprotein function, and involvement in atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2023)

Familial Hypercholesterolaemia as a Predisposing Factor for Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

The Role of Macrophages in the Pathogenesis of Atherosclerosis
por: Blagov, Alexander V., et al.
Publicado: (2023)

NLPR3 Inflammasomes and Their Significance for Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2020)

Calcifying Matrix Vesicles and Atherosclerosis
por: Chistiakov, Dimitry A., et al.
Publicado: (2017)

Lipids and Lipoproteins in Atherosclerosis
por: Bezsonov, Evgeny, et al.
Publicado: (2023)

A Novel Insight at Atherogenesis: The Role of Microbiome
por: Kirichenko, Tatiana V., et al.
Publicado: (2020)

Immune-Inflammatory Responses in Atherosclerosis: The Role of Myeloid Cells
por: Chistiakov, Dimitry A., et al.
Publicado: (2019)

Some Molecular and Cellular Stress Mechanisms Associated with Neurodegenerative Diseases and Atherosclerosis
por: Sazonova, Margarita A., et al.
Publicado: (2021)

Proprotein Convertase Subtilisin/Kexin 9 as a Modifier of Lipid Metabolism in Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2023)

Atherosclerosis Specific Features in Chronic Kidney Disease (CKD)
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Hypotheses on Atherogenesis Triggering: Does the Infectious Nature of Atherosclerosis Development Have a Substruction?
por: Lusta, Konstantin A., et al.
Publicado: (2023)

Diagnostics of atherosclerosis: Overview of the existing methods
por: Poznyak, Anastasia V., et al.
Publicado: (2023)

Modified Low Density Lipoprotein and Lipoprotein-Containing Circulating Immune Complexes as Diagnostic and Prognostic Biomarkers of Atherosclerosis and Type 1 Diabetes Macrovascular Disease
por: Orekhov, Alexander N., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jvkf9ic9f05q7eqpqfffqpg6g1